Recombinant Coronavirus 229E

Recombinant Coronavirus 229E

Catalog Number:
P001414221ABE
Mfr. No.:
Abe32-5373
Price:
  • Size:
    0.5 mg
    Quantity:
    Add to Cart:
      • Overview
        • The Recombinant Human Coronavirus 229E, E. Coli derived, 39-350 amino acids, contains the nucleocapsid immunodominant regions. The protein is fused to a His tag at C-terminal and purified by standard chromatography techniques. Human coronavirus 229E is a single-stranded, positive-sense, RNA virus species in the Alphacoronavirus genus of the subfamily Coronavirinae, in the family Coronaviridae, of the order Nidovirales. There are four globally distributed known human coronaviruses - HCoV-229E, HCoV-HKU1, HC0V-NL63 and HCoV-OC43, which are found in different locations around the world at different times of the year. Coronavirus 229E and Human coronavirus OC43 are known to be the cause for the common cold. HCoV-229E is related to large range of respiratory symptoms, from the common cold to high-morbidity diseases such as pneumonia and bronchiolitis. Additionally, between the Coronaviruses, HCoV-229E is the most frequently co-detected with other respiratory viruses, mainly with HRSV (Human respiratory syncytial virus).

          Please contact us at for specific academic pricing.

      • Properties
        • Source
          E. coli
          Type
          Recombinant Proteins
          Purification
          Protein is >95% pure as determined by 10% PAGE (coomassie staining).
          Formulation
          PBS and 3M Urea.
          Storage
          Coronavirus 229E Recombinant although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles.

          * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.